JIN KIM: Open Payments
NPI 1558371401 · RANCHO CUCAMONGA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,142 in 235 payments from 24 companies in 2025. Trend: 2023 $6,680 · 2024 $5,612 · 2025 $5,142
Food & beverage: $5,142
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 45 | $797 |
| AstraZeneca Pharmaceuticals LP | 21 | $642 |
| Alkermes, Inc. | 18 | $570 |
| PFIZER INC. | 22 | $367 |
| Abbott Laboratories | 15 | $343 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $318 |
| GlaxoSmithKline, LLC. | 17 | $247 |
| Phathom Pharmaceuticals, Inc. | 9 | $242 |
| GENZYME CORPORATION | 14 | $201 |
| Kowa Pharmaceuticals America, Inc. | 9 | $179 |
Products named: ARISTADA, BREZTRI, FREESTYLE LIBRE 3, CAPLYTA, NURTEC ODT, CREON, VOQUEZNA, TRELEGY ELLIPTA.
Industry payments across CA — which companies pay providers there.
